US FDA weighs options for warning on antihypertensive drug.
McLellan
F
F
D000959:Antihypertensive Agents / Q000009:adverse effects*; D017292:Doxazosin / Q000009:adverse effects*; D004348:Drug Labeling; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000959:Antihypertensive Agents; D017292:Doxazosin